Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 1
1990 3
1991 1
1993 1
1994 5
1995 1
1996 1
1997 7
2000 1
2001 1
2002 1
2007 3
2008 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
raf oncogenes in carcinogenesis.
Storm SM, Brennscheidt U, Sithanandam G, Rapp UR. Storm SM, et al. Among authors: brennscheidt u. Crit Rev Oncog. 1990;2(1):1-8. Crit Rev Oncog. 1990. PMID: 2091747 Review.
Molecular organization of the human Raf-1 promoter region.
Beck TW, Brennscheidt U, Sithanandam G, Cleveland J, Rapp UR. Beck TW, et al. Among authors: brennscheidt u. Mol Cell Biol. 1990 Jul;10(7):3325-33. doi: 10.1128/mcb.10.7.3325-3333.1990. Mol Cell Biol. 1990. PMID: 1694010 Free PMC article.
Pharmacokinetics of tilidine in terminal renal failure.
Seiler KU, Jähnchen E, Trenk D, Brennscheidt U, Heintz B. Seiler KU, et al. Among authors: brennscheidt u. J Clin Pharmacol. 2001 Jan;41(1):79-84. doi: 10.1177/00912700122009863. J Clin Pharmacol. 2001. PMID: 11144998 Clinical Trial.
Dacarbazine and interferon alpha for stage IV malignant melanoma.
Tamm I, Grimme H, Bergen E, Simon JC, Schöpf E, Mertelsmann R, Lindemann A, Brennscheidt U. Tamm I, et al. Among authors: brennscheidt u. Oncology. 1997 Jul-Aug;54(4):270-4. doi: 10.1159/000227701. Oncology. 1997. PMID: 9216849 Clinical Trial.
Processing of tumor tissues for vaccination with autologous tumor cells.
Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiter H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann. Lahn M, et al. Among authors: brennscheidt u. Eur Surg Res. 1997;29(4):292-302. doi: 10.1159/000129536. Eur Surg Res. 1997. PMID: 9257102
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors.
Hanauske AR, Cassidy J, Sastre J, Bolling C, Jones RJ, Rakhit A, Fettner S, Brennscheidt U, Feyereislova A, Díaz-Rubio E. Hanauske AR, et al. Among authors: brennscheidt u. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):523-31. doi: 10.1158/1078-0432.CCR-06-1627. Clin Cancer Res. 2007. PMID: 17255274 Clinical Trial.
27 results